James Hendrix

About James Hendrix

Executive Director for US Medical Affairs - donanemab, Alzheimer\'s Disease Medical Affairs Team at Eli Lilly and Company.Prior to joining Eli Lilly, was the Chief Scientific Officer for the LuMind IDSC Foundation for Down syndrome research.Prior to joining LuMind, Dr. Hendrix was director, global science initiatives, at the Alzheimer’s Association. As a member of the Medical and Scientific Relations Division, he provided leadership on specific domestic and international efforts focused on advancing the division’s science agenda. A critical element of his role is to manage industry consortia such as the Alzheimer’s Association Research Roundtable (AARR); lead the Global Biomarker Standardization Consortium; manage and direct future meeting efforts and output; and assist with the coordination of the $100 million dollar Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study on the clinical usefulness of amyloid PET imaging.Medicinal Chemist with over 18 years of experience in the pharmaceutical industry, most of it spent with Sanofi or its’ predecessor companies. Nine years of proven management experience leading groups of various sizes.Experience in the biotech industry as the former President of Technology for nPharmakon and the Director of Chemistry for Oligomerix.Contact me at:(908) 6••••••••@yahoo.comSpecialties: Technology Management, Pharmaceutical, Biotechnology, Neuroscience, Healthcare, International / CRO Collaboration, Scientific leadership, Drug Discovery, CNS diseases, Medicinal Chemistry, Organic Synthesis, Management of people and budgets, Effective communicator.

Experience

1. Executive Director for Us Medical Affairs

   Eli Lilly and Company

   Apr 2022 — Present · Indianapolis, IN, US

   Member of the Alzheimer\'s Disease Medical Affairs team in the Neuroscience Business Unit. As a clinical research scientist is responsible for collaborating internally, externally, and across functions to support medical affairs transformation activities and develop strategically aligned medical content to support healthy AD ecosystems.

Education

• Colorado State University

  PhD, Chemistry

  1984 — 1993

• University of Northern Colorado

  BA, Chemistry

  1980 — 1985

Skills

• Lead Change
• Formulation
• • Strong Written and Oral Communication Skills
• CRO
• Chemistry
• Hplc
• Communication
• Communicator
• Technology Transfer
• Scifinder
• Ability to Lead Multi-Disciplinary Teams
• Nmr
• Mass Spectrometry
• Medicinal Chemistry
• Heterocyclic Chemistry
• Science
• Lifesciences
• Purification
• Protein Chemistry
• Chromatography
• Drug Design
• Synthetic Chemistry
• Lead Optimization
• Drug Development
• Drug Delivery
• Clinical Trials
• Organic Chemistry
• Biopharmaceuticals
• Patents
• Gpcrs
• Adme
• Glp
• Analytical Chemistry
• Biotechnology
• Scientific Management
• Molecular Modeling
• Parallel Synthesis
• R&D
• High Throughput Screening
• Clinical Development